TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 5nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 13nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 15nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 25nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 55nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 34nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 18nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 11nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 18nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 282nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 23nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 3nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 9nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 23nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 31nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 12nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 5nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 84nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 10nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 9nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 20nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 12nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 13nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 58nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 13nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 45nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 5nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 41nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 23nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 733nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 85nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 120nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 18nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 29nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 62nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 9nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 17nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
TargetFree fatty acid receptor 1(Homo sapiens (Human))
Boehringer Ingelheim International GmbH
US Patent
Boehringer Ingelheim International GmbH
US Patent
Affinity DataEC50: 4nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
